TrialNature medicine2021

Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial.

Man-Fung Yuen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.